Adherence to Study Medication Compared to Generic Topical Clindamycin Plus Generic Topical Tretinoin in Subjects With Mild to Moderate Acne Vulgaris

Inclusion Criteria:

- Males or Females 12 years of age or older with a diagnosis of mild to moderate acne
vulgaris.

- Subjects must sign written informed consent and agree to come for all study visits.

Exclusion Criteria:

- Use of experimental drugs within 1 month prior to initiation of study therapy.

- Pregnant and nursing females will not be allowed in the study, and females of
childbearing potential will have a pregnancy test at baseline. Females of childbearing
potential must agree to use approved birth control methods for the duration of the
study.

- Use of systemic retinoids within 2 months of enrollment, use of any topical retinoids,
systemic antibiotics, nicotinamide, systemic steroids or any other medication that may
confound the results of the study within 1 month prior to start of the study

- Use of any other topical medications for acne, including cosmetics containing retinol,
within 2 weeks prior to study entry.

- Any skin condition or disease that may require concurrent therapy or may confound the
evaluation;

- History of hypersensitivity to any of the formulation components;

- Facial skin cancer or facial actinic keratosis;

- Use of any photosensitizing agents.

- Use of isotretinoin within the last 6 months.

- Chemical peels, microdermabrasion or laser resurfacing within 3 months of study entry.

- Crohns disease, ulcerative colitis, or have developed colitis with past antibiotic
use.